Losartan induced fetal toxicity.

Simple item page
dc.contributor.authorNayar, Bonillaen_US
dc.contributor.authorSinghal, Ashwanien_US
dc.contributor.authorAggarwal, Rajiven_US
dc.contributor.authorMalhotra, Neenaen_US
dc.date.accessioned2003-11-02en_US
dc.date.accessioned2009-05-30T12:44:38Z
dc.date.available2003-11-02en_US
dc.date.available2009-05-30T12:44:38Z
dc.date.issued2003-11-02en_US
dc.description.abstractLosartan is a specific angiotensin II receptor antagonist. Although the teratogenic effects of angiotensin converting enzyme (ACE) inhibitors are well documented there are limited reports of losartan induced fetal toxicity. The authors report a case of incomplete ossification of skull bones, transient oliguria and feed intolerance in a newborn following in-utero exposure to losartan.en_US
dc.description.affiliationDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.en_US
dc.identifier.citationNayar B, Singhal A, Aggarwal R, Malhotra N. Losartan induced fetal toxicity. Indian Journal of Pediatrics. 2003 Nov; 70(11): 923-4en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/80994
dc.language.isoengen_US
dc.source.urihttps://medind.nic.in/icb/icbai.shtmlen_US
dc.subject.meshAbnormalities, Drug-Induceden_US
dc.subject.meshAntihypertensive Agents --poisoningen_US
dc.subject.meshFemaleen_US
dc.subject.meshFetal Death --chemically induceden_US
dc.subject.meshHeart Defects, Congenital --drug therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshLosartan --poisoningen_US
dc.subject.meshPregnancyen_US
dc.subject.meshPregnancy Complications, Cardiovascular --drug therapyen_US
dc.titleLosartan induced fetal toxicity.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Pediatrics